Page last updated: 2024-08-23

cetylpyridinium chloride anhydrous and Tachycardia, Ventricular

cetylpyridinium chloride anhydrous has been researched along with Tachycardia, Ventricular in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bär, H; Ehlermann, P; Geiger, SK; Herrmann, H; Ivandic, BT; Katus, HA; Rutschow, D; Wälde, S; Weichenhan, D; Zeller, R; Zentgraf, H1

Other Studies

1 other study(ies) available for cetylpyridinium chloride anhydrous and Tachycardia, Ventricular

ArticleYear
Incomplete nonsense-mediated decay of mutant lamin A/C mRNA provokes dilated cardiomyopathy and ventricular tachycardia.
    Journal of molecular medicine (Berlin, Germany), 2008, Volume: 86, Issue:3

    Topics: Adult; Alleles; Cardiomyopathy, Dilated; Case-Control Studies; Cell Nucleus; Chromatin; Codon, Nonsense; Down-Regulation; Female; Fibroblasts; Health; Humans; Lamin Type A; Male; Mutant Proteins; Myocardium; Nuclear Proteins; Pedigree; Proteasome Inhibitors; RNA Stability; RNA, Messenger; Skin; Tachycardia, Ventricular

2008